These mechanisms are worth mentioning since if the results in this latest correspondence in the NEJM are indeed replicated, there is a large difference if these effects are occurring either a) Because pancreatic beta cells are dying less b) Because pancreatic beta cells are growing back c) Because pancreatic beta cells are not being targeted by the immune system anymore If replicated, I find a) and b) to be the most likely reasons
The five new genes from the 4 hrs time point could represent additional GLP-1LAG-1 transcriptional targets, which have longer RNA half-lives than lst-1 and sygl-1 , or they may represent changes in RNA level that are secondary effects of GLP-1 signaling
Tirzepatide's dual incretin agonism produces substantial weight loss and marked improvements in insulin sensitivity, making it theoretically relevant for metabolic aspects of PCOS management
Stages 3/4 usually need clinic-based interventions, with home methods playing a supporting role
Full performance and physical benefits generally develop over 8 to 12 weeks of consistent use
With a 5 mg/mL vial: 10 units = 0.5 mg = second dose level (weeks 5-8)